PDSB
PDS Biotechnology Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.22
+0.23%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
940.6%
Return on equity
-382.3%
Return on assets
-3550.4%
Return on invested capital
0.00x
Asset turnover
-$16.8M
Cash from operations
$0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026